Kerntke Otto McGlone Wealth Management Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,646
Closed -$204K 80
2024
Q2
$204K Sell
1,646
-14
-0.8% -$1.8K 0.19% 72
2024
Q1
$219K Buy
+1,660
New +$205K 0.22% 66
2021
Q3
Sell
-9,982
Closed -$776K 97
2021
Q2
$776K Sell
9,982
-632
-6% -$47K 0.31% 54
2021
Q1
$781K Buy
10,614
+1,180
+13% +$87K 0.41% 50
2020
Q4
$736K Buy
9,434
+117
+1% +$8.95K 0.43% 52
2020
Q3
$737K Buy
9,317
+1,422
+18% +$111K 0.54% 49
2020
Q2
$582K Buy
7,895
+365
+5% +$27.5K 0.53% 47
2020
Q1
$553K Buy
7,530
+319
+4% +$25.1K 0.62% 44
2019
Q4
$626K Buy
+7,211
New +$592K 0.53% 52

Other funds holding MRK

Kerntke Otto McGlone Wealth Management Group's MRK Position: Q3 2024 in Review

Kerntke Otto McGlone Wealth Management Group sold out of Merck (MRK) in Q3 2024, closing a stake of 1,646 shares — an estimated $204K sold.

Kerntke Otto McGlone Wealth Management Group first reported a position in MRK in Q4 2019 and held it in 9 quarters. The position peaked at $781K in Q1 2021. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Kerntke Otto McGlone Wealth Management Group reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Kerntke Otto McGlone Wealth Management Group sold 1,646 Merck shares in Q3 2024, an estimated $204K.
  • Kerntke Otto McGlone Wealth Management Group first reported a position in Merck in Q4 2019 and held it in 9 quarters.
  • Kerntke Otto McGlone Wealth Management Group's Merck position peaked at $781K in Q1 2021.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Kerntke Otto McGlone Wealth Management Group's 13F filing for Q3 2024, filed 12 Nov 2024.